Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
20 hedge funds and large institutions have $1.71M invested in Nemaura Medical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 19 → 20 (+1)
21% less capital invested
Capital invested by funds: $2.16M → $1.71M (-$442K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.54K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$510 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$114 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32.7K |
| 2 |
AIP
ARS Investment Partners
New York
|
-$11.4K |
| 3 |
BlackRock
New York
|
-$1.5K |
| 4 |
GIA
GHP Investment Advisors
Denver,
Colorado
|
-$1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$460 |
NMRD Hedge Fund Activity: Q3 2022 in Review
20 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2022, worth a combined $1.71M — down 21% from $2.16M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NMRD positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, adding an estimated $11.3K. The largest seller was Susquehanna International Group, cutting an estimated $32.7K.
- 20 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2022, up from 19 in Q2 2022.
- Funds reported $1.71M of Nemaura Medical, Inc. Common Stock stock for Q3 2022, down 21% quarter-over-quarter.
- 2 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2022 was UBS Group, an estimated $11.3K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q3 2022 was Susquehanna International Group, an estimated $32.7K sold.
Based on aggregated 13F filings for Q3 2022.